CHF 17454

Drug Profile

CHF 17454

Alternative Names: JL 17454; Lirexapride

Latest Information Update: 29 May 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Chiesi; Logeais
  • Developer Logeais
  • Class Benzamides; Gastrokinetics
  • Mechanism of Action Dopamine D2 receptor agonists; Serotonin 4 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Irritable bowel syndrome

Most Recent Events

  • 29 May 2001 Discontinued-II for Irritable bowel syndrome in France (Unknown route)
  • 27 Nov 2000 Profile reviewed but no significant changes made
  • 05 Sep 2000 JL 17454 is now called CHF 17454
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top